rs199919568

Variant summary

Our verdict is Likely pathogenic. The variant received 7 ACMG points: 7P and 0B. PVS1_ModeratePS3PP5

The NM_007254.4(PNKP):​c.1029+2T>C variant causes a splice donor, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00178 in 1,280,492 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). ClinVar reports functional evidence for this variant: "SCV000242059: RNA studies and functional RNA analyses demonstrate a damaging effect and indicate aberrant splicing in response to c.1029+2T>C resulting predominately in skipping of exon 11, affecting the phosphatase domain and the kinase domain (PMID:37301908, 34697416, 22508754)" and additional evidence is available in ClinVar.

Frequency

Genomes: 𝑓 0.0011 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0019 ( 0 hom. )

Consequence

PNKP
NM_007254.4 splice_donor, intron

Scores

3
3
Splicing: ADA: 1.000
2

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications P:26U:3

Conservation

PhyloP100: 3.19

Publications

12 publications found
Variant links:
Genes affected
PNKP (HGNC:9154): (polynucleotide kinase 3'-phosphatase) This locus represents a gene involved in DNA repair. In response to ionizing radiation or oxidative damage, the protein encoded by this locus catalyzes 5' phosphorylation and 3' dephosphorylation of nucleic acids. Mutations at this locus have been associated with microcephaly, seizures, and developmental delay.[provided by RefSeq, Sep 2010]
PNKP Gene-Disease associations (from GenCC):
  • ataxia - oculomotor apraxia type 4
    Inheritance: AR Classification: DEFINITIVE, SUPPORTIVE Submitted by: Laboratory for Molecular Medicine, G2P, Orphanet
  • microcephaly, seizures, and developmental delay
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, ClinGen
  • Charcot-Marie-Tooth disease type 2B2
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae)
  • genetic developmental and epileptic encephalopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_pathogenic. The variant received 7 ACMG points.

PVS1
Splicing +-2 bp (donor or acceptor) variant, product NOT destroyed by NMD, known LOF gene, truncates exone, which is 0.059386972 fraction of the gene. No cryptic splice site detected. Exon removal is inframe change.
PS3
PS3 evidence extracted from ClinVar submissions: SCV000242059: RNA studies and functional RNA analyses demonstrate a damaging effect and indicate aberrant splicing in response to c.1029+2T>C resulting predominately in skipping of exon 11, affecting the phosphatase domain and the kinase domain (PMID: 37301908, 34697416, 22508754); SCV003922343: RNAseq showed exon 11 skipping, which is in-frame and is predicted to escape nonsense mediated decay (NMD) (Neuser 2021 PMID: 34697416; Wai 2020 PMID: 32123317).; SCV000650110: Studies have shown that disruption of this splice site results in skipping of exon 11 and/or intron 10 retention , and produces a non-functional protein and/or introduces a premature termination codon (PMID: 34697416, 37301908).; SCV006071667: Several computational tools predict a significant impact on normal splicing: Four predict the variant abolishes a 5' splicing donor site. Two publications report experimental evidence that this variant affects mRNA splicing (Wai_2020, Oddsson_2023).; SCV002694485: RNA studies have demonstrated that this alteration results in abnormal splicing in the set of samples tested (Oddsson, 2023; Wai, 2020; Neuser, 2022).; SCV003920336: RNA studies predict that this variant will impact the protein with altered splicing (Wai 2020 PMID:32123317).
PP5
Variant 19-49862369-A-G is Pathogenic according to our data. Variant chr19-49862369-A-G is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 206401.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_007254.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PNKP
NM_007254.4
MANE Select
c.1029+2T>C
splice_donor intron
N/ANP_009185.2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PNKP
ENST00000322344.8
TSL:1 MANE Select
c.1029+2T>C
splice_donor intron
N/AENSP00000323511.2Q96T60-1
PNKP
ENST00000596014.5
TSL:1
c.1029+2T>C
splice_donor intron
N/AENSP00000472300.1Q96T60-1
PNKP
ENST00000593946.5
TSL:1
n.*956+2T>C
splice_donor intron
N/AENSP00000468896.1M0QX49

Frequencies

GnomAD3 genomes
AF:
0.00109
AC:
157
AN:
144138
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000203
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.000602
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000236
Gnomad FIN
AF:
0.00200
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00195
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.00106
AC:
158
AN:
149072
AF XY:
0.00109
show subpopulations
Gnomad AFR exome
AF:
0.000525
Gnomad AMR exome
AF:
0.000328
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00135
Gnomad NFE exome
AF:
0.00212
Gnomad OTH exome
AF:
0.000943
GnomAD4 exome
AF:
0.00187
AC:
2120
AN:
1136252
Hom.:
0
Cov.:
34
AF XY:
0.00179
AC XY:
1016
AN XY:
567000
show subpopulations
African (AFR)
AF:
0.000156
AC:
4
AN:
25714
American (AMR)
AF:
0.000385
AC:
13
AN:
33732
Ashkenazi Jewish (ASJ)
AF:
0.000139
AC:
3
AN:
21546
East Asian (EAS)
AF:
0.00
AC:
0
AN:
29442
South Asian (SAS)
AF:
0.0000674
AC:
5
AN:
74186
European-Finnish (FIN)
AF:
0.00130
AC:
54
AN:
41656
Middle Eastern (MID)
AF:
0.000263
AC:
1
AN:
3802
European-Non Finnish (NFE)
AF:
0.00229
AC:
1972
AN:
859300
Other (OTH)
AF:
0.00145
AC:
68
AN:
46874
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
117
234
351
468
585
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
74
148
222
296
370
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00109
AC:
157
AN:
144240
Hom.:
0
Cov.:
32
AF XY:
0.00115
AC XY:
81
AN XY:
70546
show subpopulations
African (AFR)
AF:
0.000202
AC:
8
AN:
39558
American (AMR)
AF:
0.00
AC:
0
AN:
14670
Ashkenazi Jewish (ASJ)
AF:
0.000602
AC:
2
AN:
3324
East Asian (EAS)
AF:
0.00
AC:
0
AN:
4634
South Asian (SAS)
AF:
0.000237
AC:
1
AN:
4228
European-Finnish (FIN)
AF:
0.00200
AC:
19
AN:
9504
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
292
European-Non Finnish (NFE)
AF:
0.00195
AC:
127
AN:
65136
Other (OTH)
AF:
0.00
AC:
0
AN:
2028
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.512
Heterozygous variant carriers
0
6
13
19
26
32
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00153
Hom.:
0
Bravo
AF:
0.000854
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.00123
AC:
10
ExAC
AF:
0.000272
AC:
27

ClinVar

ClinVar submissions
Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
9
-
-
Microcephaly, seizures, and developmental delay (9)
9
-
-
not provided (9)
3
-
-
Ataxia - oculomotor apraxia type 4 (3)
1
-
-
Abnormal cerebral morphology (1)
1
-
-
Charcot-Marie-Tooth disease type 2B2;C3150667:Microcephaly, seizures, and developmental delay;C4225397:Ataxia - oculomotor apraxia type 4 (1)
1
-
-
Developmental and epileptic encephalopathy, 12 (1)
1
-
-
Inborn genetic diseases (1)
-
1
-
Microcephaly (1)
1
-
-
Microcephaly, seizures, and developmental delay;C4225397:Ataxia - oculomotor apraxia type 4 (1)
-
1
-
not specified (1)
-
1
-
PNKP-related disorder (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Pathogenic
0.30
D
BayesDel_noAF
Uncertain
0.050
CADD
Uncertain
25
DANN
Uncertain
0.99
Eigen
Pathogenic
0.96
Eigen_PC
Pathogenic
0.78
FATHMM_MKL
Uncertain
0.92
D
PhyloP100
3.2
GERP RS
5.1
Mutation Taster
=3/97
disease causing (ClinVar)

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Pathogenic
1.0
dbscSNV1_RF
Pathogenic
0.93
Splicevardb
3.0
SpliceAI score (max)
0.93
Details are displayed if max score is > 0.2
DS_DL_spliceai
0.93
Position offset: 2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs199919568; hg19: chr19-50365626; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.